Loading streams...
| All Content |
| RSS |
| View all podcasts & RSS feeds | ||
Reporting inThe Lancet, researchers write that a preliminary study shows embryonic stem cell therapy in two patients with macular degeneration was safe. Results suggest the patients' vision improved slightly. Dr. Robert Lanza, Chief Scientific Officer of Advanced Cell Technology and co-author of the study, discusses the trial.